Business
Zentek Announces Eric Wallman Appointed as Chairman of the Board
GUELPH, ON / ACCESSWIRE / January 19, 2024 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq...
About this update from Zentek Ltd.
[{"type":"text","content":"Zentek Announces Eric Wallman Appointed as Chairman of the BoardGUELPH, ON / ACCESSWIRE / January 19, 2024 / Zentek Ltd. (\"Zentek\" or the \"Company\") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces that effective January 12th, Dr. Francis Dubé has resigned as Chairman of the Board of the Company in order to appoint an independent director, Mr. Eric Wallman as the Chairman of the Board as per best practices in governance. Mr. Wallman has been an independent director of the Company since 2018 and served as head of the audit committee as well as being on the compensation and the strategy committees. Dr. Dubé will continue to serve the Company as a director, and as Chief Operating Officer of the Company.Greg Fenton, CEO commented: \"On behalf of the Board, I would like to thank Dr. Dubé for his services as Chairman of the Board of Zentek. As we continue to grow and move to the next stage of our development, the Board is committed to best practices in governance, which includes an independent Chairman. I would also like to thank Mr. Wallman for accepting the role as an independent director in order to continue bolstering Zentek's commitment to good governance.\"About ZentekZentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.Zentek's patented technology platform ZenGUARD™, is shown to have 99% anti-microbial activity and to significantly increase the bacterial and viral filtration efficiency of both surgical masks and HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.Zentek has a global exclusive license to the Aptamer-based platform technology developed by McMaster University which is being jointly developed by Zentek and McMaster for both the diagnostic and therapeutic markets.For further information about Zentek or Albany Graphite Corp.:Dr. Francis Dubé, director and Chief Operating OfficerTel: (289) 821-2820Email: [email protected] find out more about Zentek Ltd., please visit our website at www.Zentek.com. A copy of this news re...